Your browser doesn't support javascript.
loading
Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosis.
Yamada, Kazuhisa; Tazaki, Akira; Ushio-Watanabe, Nanako; Usui, Yoshihiko; Takeda, Atsunobu; Matsunaga, Masaaki; Suzumura, Ayana; Shimizu, Hideyuki; Zheng, Hao; Ariefta, Nanang R; Yamamoto, Masahiro; Hara, Hideaki; Goto, Hiroshi; Sonoda, Koh-Hei; Nishiguchi, Koji M; Kato, Masashi; Nishikawa, Yoshifumi; Toyokuni, Shinya; Kaneko, Hiroki.
Afiliação
  • Yamada K; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: speed_of_sound_340ms@icloud.com.
  • Tazaki A; Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: atazaki@med.nagoya-u.ac.jp.
  • Ushio-Watanabe N; National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, 080-8555, Japan. Electronic address: nanakoushio75@gmail.com.
  • Usui Y; Department of Ophthalmology, Tokyo Medical University, Tokyo, 160-8402, Japan. Electronic address: usuyoshi@gmail.com.
  • Takeda A; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: takeda.atsunobu.248@m.kyushu-u.ac.jp.
  • Matsunaga M; Department of Public Health, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan. Electronic address: mm-223@fujita-hu.ac.jp.
  • Suzumura A; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: a.suzumura@med.nagoya-u.ac.jp.
  • Shimizu H; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: hideshimingy@yahoo.co.jp.
  • Zheng H; Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: zhenghao@med.nagoya-u.ac.jp.
  • Ariefta NR; National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, 080-8555, Japan. Electronic address: nanang.ariefta@gmail.com.
  • Yamamoto M; Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan. Electronic address: myamamoto@biken.osaka-u.ac.jp.
  • Hara H; Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Gifu, 501-1196, Japan. Electronic address: hidehara@gifu-pu.ac.jp.
  • Goto H; Department of Ophthalmology, Tokyo Medical University, Tokyo, 160-8402, Japan. Electronic address: goto1115@tokyo-med.ac.jp.
  • Sonoda KH; Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: k.sonoda.a74@m.kyushu-u.ac.jp.
  • Nishiguchi KM; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: kmn@med.nagoya-u.ac.jp.
  • Kato M; Department of Occupational and Environmental Health, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: katomasa@med.nagoya-u.ac.jp.
  • Nishikawa Y; National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, 080-8555, Japan. Electronic address: nisikawa@obihiro.ac.jp.
  • Toyokuni S; Department of Pathology and Biological Responses, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan; Center for Low-Temperature Plasma Sciences, Nagoya University, Furo-Cho, Chikusa-ku, Nagoya, 464-8603, Japan. Electronic address: toyokuni@med.nagoya-u.ac.jp.
  • Kaneko H; Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. Electronic address: h-kaneko@med.nagoya-u.ac.jp.
Redox Biol ; 67: 102890, 2023 11.
Article em En | MEDLINE | ID: mdl-37738924
Toxoplasmosis is a major infectious disease, affecting approximately one-third of the world's population; its main clinical manifestation, ocular toxoplasmosis (OT), is a severe sight-threatening disease. Nevertheless, the diagnosis of OT is based on clinical findings, which needs improvement, even with biochemical tests, such as polymerase chain reaction and antibody detections. Furthermore, the efficacy of OT-targeted treatment is limited; thus, additional measures for diagnosis and treatments are needed. Here, we for the first time report a significantly reduced iron concentration in the vitreous humor (VH) of human patients infected with OT. To obtain further insights into molecular mechanisms, we established a mouse model of T. gondii infection, in which intravitreally injected tracer 57Fe, was accumulated in the neurosensory retina. T. gondii-infected eyes showed increased lipid peroxidation, reduction of glutathione peroxidase-4 expression and mitochondrial deformity in the photoreceptor as cristae loss. These findings strongly suggest the involvement of ferroptotic process in the photoreceptor of OT. In addition, deferiprone, an FDA-approved iron chelator, reduced the iron uptake but also ameliorated toxoplasma-induced retinochoroiditis by reducing retinal inflammation. In conclusion, the iron levels in the VH could serve as diagnostic markers and iron chelators as potential treatments for OT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxoplasma / Toxoplasmose Ocular / Coriorretinite / Ferroptose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Redox Biol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxoplasma / Toxoplasmose Ocular / Coriorretinite / Ferroptose Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Redox Biol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Holanda